For decades, the United States has led the world in biotechnology innovation. But that dominance is now under threat from China’s rapid advances in biotech, triggering growing concern in Washington. In a newly released report this week, a congressionally mandated panel delivered a stark warning: the U.S. is “dangerously close to falling behind China” in a field that could define economic and military power in the 21st century. American officials are waking up to a new reality that biotechnology – from drug development to genetic engineering – is becoming a geopolitical battleground.
Genetic code displayed on a screen — a representation of the cutting-edge biotechnology that is now central to U.S.–China strategic competition. » Read More
